The Use of Bevacizumab as a Modulator of Wound Healing Following Trabeculectomy Surgery
Status:
Completed
Trial end date:
2019-05-01
Target enrollment:
Participant gender:
Summary
This is a phase III randomised controlled pilot study which aims to assess the effectiveness
of the use of bevacizumab in patients who have undergone trabeculectomy surgery, which appear
to be showing early signs of failure.